Caillol Fabrice, Godat Sébastien, Solovyev Alexey, Harouchi Amina, Oumrani Sarra, Marx Mariola, Hoibian Solene, Dahel Yanis, Ratone Jean-Philippe, Giovannini Marc
Endoscopy Unit, Paoli-Calmettes Institute, Marseille, France.
gastroentérologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Endosc Int Open. 2024 Mar 7;12(3):E377-E384. doi: 10.1055/a-2261-2968. eCollection 2024 Mar.
In cases of inaccessible papilla, EUS-guided biliary drainage (EUS-BD) has been described as an alternative to calibrate benign biliary stenosis. However, few studies are available. This tw-center, retrospective study was designed to evaluate technical success and clinical success at 1 year. All patients who underswent EUS-BD without the rendezvous technique used for calibration of benign biliary stenosis were included from 2016 to 2022. Patients underwent EUS-hepaticogastrostomy (EUS-HGS) during the first session. Then, HGS was used to access the bile duct, allowing calibration of the stenosis: Dilation of the biliary stenosis and placement of double pigtail stents through the stenosis for 1 year. Thirty-six patients were included. Technical success was 89% (32/36), with four failures to cross the stenosis but EUS-HGS was performed in 100% of the cases. Nine patients were excluded during calibration because of oncological relapse in six and complex stenosis in three. Three patients had not yet reached 1 year of follow-up. Twenty patients had a calibration for at least 1 year. Clinical success after stent placement was considered in all cases after 1 year of follow-up. Thirteen patients underwent stent removal and no relapse occurred after 435 days of follow-up (SD=568). Global morbidity was 41.7% (15/36) with only one serious complication (needing intensive care), including seven cases of cholangitis due to intrabiliary duct obstruction and five stent migrations. No deaths were reported. EUS-BD for calibration in case of benign biliary stenosis is an option. Dedicated materials are needed to decrease morbidity.
在乳头难以到达的情况下,内镜超声引导下胆道引流术(EUS-BD)已被描述为校准良性胆管狭窄的一种替代方法。然而,相关研究较少。这项双中心回顾性研究旨在评估1年时的技术成功率和临床成功率。纳入了2016年至2022年期间所有接受EUS-BD且未使用会师技术校准良性胆管狭窄的患者。患者在首次手术时接受内镜超声引导下肝胃吻合术(EUS-HGS)。然后,通过HGS进入胆管,对狭窄进行校准:扩张胆管狭窄并通过狭窄处放置双猪尾支架1年。共纳入36例患者。技术成功率为89%(32/36),有4例未能穿过狭窄,但100%的病例都进行了EUS-HGS。在校准过程中有9例患者被排除,其中6例是因为肿瘤复发,3例是因为复杂狭窄。3例患者尚未达到1年的随访时间。20例患者进行了至少1年的校准。随访1年后,所有病例均考虑支架置入后的临床成功率。13例患者取出了支架,随访435天(标准差=568)后无复发。总体发病率为41.7%(15/36),只有1例严重并发症(需要重症监护),包括7例因胆管内梗阻引起的胆管炎和5例支架移位。无死亡报告。对于良性胆管狭窄的校准,EUS-BD是一种选择。需要专用材料来降低发病率。